BTN3A2 and ischemic stroke: Among novel targets, BTN3A2 had a relatively large protective effect on ischemic stroke (Figure 3; Figure S3, Supporting Information), and the results were consistent across 4 MR methods with balanced horizontal pleiotropy tested with MR Egger intercept (Table S10, Supporting Information).